{"id":"https://openalex.org/W2071881749","doi":"https://doi.org/10.1111/j.1476-5381.1990.tb14695.x","title":"Modulation of seizure susceptibility in the mouse by the strychnine\u2010insensitive glycine recognition site of the NMDA receptor/ion channel complex","display_name":"Modulation of seizure susceptibility in the mouse by the strychnine\u2010insensitive glycine recognition site of the NMDA receptor/ion channel complex","alternate_titles":[],"publication_year":1990,"publication_date":"1990-02-01","ids":{"openalex":"https://openalex.org/W2071881749","doi":"https://doi.org/10.1111/j.1476-5381.1990.tb14695.x","mag":"2071881749","pmid":"https://pubmed.ncbi.nlm.nih.gov/1691674","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1917378"},"language":"en","primary_location":{"id":"doi:10.1111/j.1476-5381.1990.tb14695.x","doi":"https://doi.org/10.1111/j.1476-5381.1990.tb14695.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1476-5381.1990.tb14695.x","pdf_url":null,"source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2071881749"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1917378/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103470279","display_name":"Lakhbir Singh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087189","display_name":"MSD (UK) Limited (United Kingdom)","ror":"https://ror.org/004nn4n27","country_code":"GB","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210087189"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"L. Singh","raw_affiliation_strings":["Merck Sharp & Dohme Research Laboratories, Neuroscience Research Centre, Harlow, Essex","Merck Sharp & Dohme Research Laboratories, Neuroscience Research Centre, Terlings Park, Eastwick Road, Harlow, Essex CM20 2QR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Sharp & Dohme Research Laboratories, Neuroscience Research Centre, Harlow, Essex","institution_ids":["https://openalex.org/I4210087189"]},{"raw_affiliation_string":"Merck Sharp & Dohme Research Laboratories, Neuroscience Research Centre, Terlings Park, Eastwick Road, Harlow, Essex CM20 2QR","institution_ids":["https://openalex.org/I4210087189"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024043400","display_name":"Ryszard J. Oles","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087189","display_name":"MSD (UK) Limited (United Kingdom)","ror":"https://ror.org/004nn4n27","country_code":"GB","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210087189"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"R.J. Oles","raw_affiliation_strings":["Merck Sharp & Dohme Research Laboratories, Neuroscience Research Centre, Terlings Park, Eastwick Road, Harlow, Essex CM20 2QR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Sharp & Dohme Research Laboratories, Neuroscience Research Centre, Terlings Park, Eastwick Road, Harlow, Essex CM20 2QR","institution_ids":["https://openalex.org/I4210087189"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5067902930","display_name":"Mark David Tricklebank","orcid":"https://orcid.org/0000-0002-9949-6290","observed_orcids":["https://orcid.org/0000-0002-9949-6290"]},"institutions":[{"id":"https://openalex.org/I4210087189","display_name":"MSD (UK) Limited (United Kingdom)","ror":"https://ror.org/004nn4n27","country_code":"GB","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210087189"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"M.D. Tricklebank","raw_affiliation_strings":["Merck Sharp & Dohme Research Laboratories, Neuroscience Research Centre, Terlings Park, Eastwick Road, Harlow, Essex CM20 2QR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Sharp & Dohme Research Laboratories, Neuroscience Research Centre, Terlings Park, Eastwick Road, Harlow, Essex CM20 2QR","institution_ids":["https://openalex.org/I4210087189"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5067902930"],"corresponding_institution_ids":["https://openalex.org/I4210087189"],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":5.9429,"has_fulltext":false,"cited_by_count":117,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.97716137,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"99","issue":"2","first_page":"285","last_page":"288"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.5,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.5,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.42899999022483826,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12770","display_name":"Amino Acid Enzymes and Metabolism","score":0.020099999383091927,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nmda-receptor","display_name":"NMDA receptor","score":0.9259999990463257},{"id":"https://openalex.org/keywords/d-serine","display_name":"D-serine","score":0.9580000042915344},{"id":"https://openalex.org/keywords/seizure-susceptibility","display_name":"seizure susceptibility","score":0.9390000104904175},{"id":"https://openalex.org/keywords/epilepsy","display_name":"epilepsy","score":0.6190000176429749},{"id":"https://openalex.org/keywords/pentylenetetrazole","display_name":"pentylenetetrazole","score":0.8870000243186951},{"id":"https://openalex.org/keywords/kynurenic-acid","display_name":"kynurenic acid","score":0.984000027179718},{"id":"https://openalex.org/keywords/7-chlorokynurenic-acid","display_name":"7-chlorokynurenic acid","score":0.9810000061988831},{"id":"https://openalex.org/keywords/cpp","display_name":"CPP","score":0.5400000214576721},{"id":"https://openalex.org/keywords/anticonvulsant-activity","display_name":"anticonvulsant activity","score":0.7919999957084656},{"id":"https://openalex.org/keywords/audiogenic-seizures","display_name":"audiogenic seizures","score":0.6930000185966492},{"id":"https://openalex.org/keywords/dba-2-mice","display_name":"DBA/2 mice","score":0.8240000009536743},{"id":"https://openalex.org/keywords/swiss-webster-mice","display_name":"Swiss Webster mice","score":0.722000002861023}],"concepts":[{"id":"https://openalex.org/C2777725853","wikidata":"https://www.wikidata.org/wiki/Q194406","display_name":"Strychnine","level":2,"score":0.8966498374938965},{"id":"https://openalex.org/C35599011","wikidata":"https://www.wikidata.org/wiki/Q426887","display_name":"Glycine receptor","level":4,"score":0.7954028844833374},{"id":"https://openalex.org/C50254741","wikidata":"https://www.wikidata.org/wiki/Q62536","display_name":"Ion channel","level":3,"score":0.6336042284965515},{"id":"https://openalex.org/C67018056","wikidata":"https://www.wikidata.org/wiki/Q414896","display_name":"NMDA receptor","level":3,"score":0.6124076843261719},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.6091111898422241},{"id":"https://openalex.org/C82617044","wikidata":"https://www.wikidata.org/wiki/Q418536","display_name":"Ligand-gated ion channel","level":4,"score":0.5288894176483154},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5192937254905701},{"id":"https://openalex.org/C123079801","wikidata":"https://www.wikidata.org/wiki/Q750240","display_name":"Modulation (music)","level":2,"score":0.5113615393638611},{"id":"https://openalex.org/C2777756961","wikidata":"https://www.wikidata.org/wiki/Q620730","display_name":"Glycine","level":3,"score":0.5017681121826172},{"id":"https://openalex.org/C2778851735","wikidata":"https://www.wikidata.org/wiki/Q407324","display_name":"Phencyclidine","level":4,"score":0.4225216209888458},{"id":"https://openalex.org/C12554922","wikidata":"https://www.wikidata.org/wiki/Q7100","display_name":"Biophysics","level":1,"score":0.4170117974281311},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3727763295173645},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.26820647716522217},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.21791395545005798},{"id":"https://openalex.org/C515207424","wikidata":"https://www.wikidata.org/wiki/Q8066","display_name":"Amino acid","level":2,"score":0.10501512885093689},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.09045478701591492},{"id":"https://openalex.org/C24890656","wikidata":"https://www.wikidata.org/wiki/Q82811","display_name":"Acoustics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000161","descriptor_name":"Acoustic Stimulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001224","descriptor_name":"Aspartic Acid","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D003975","descriptor_name":"Diazepam","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007276","descriptor_name":"Injections, Intraventricular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007473","descriptor_name":"Ion Channels","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D007736","descriptor_name":"Kynurenic Acid","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D007736","descriptor_name":"Kynurenic Acid","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008811","descriptor_name":"Mice, Inbred DBA","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010433","descriptor_name":"Pentylenetetrazole","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012640","descriptor_name":"Seizures","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D012640","descriptor_name":"Seizures","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D012694","descriptor_name":"Serine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013331","descriptor_name":"Strychnine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D016194","descriptor_name":"Receptors, N-Methyl-D-Aspartate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016202","descriptor_name":"N-Methylaspartate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017981","descriptor_name":"Receptors, Neurotransmitter","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D018009","descriptor_name":"Receptors, Glycine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/j.1476-5381.1990.tb14695.x","doi":"https://doi.org/10.1111/j.1476-5381.1990.tb14695.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1476-5381.1990.tb14695.x","pdf_url":null,"source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:1917378","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1917378/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Pharmacol","raw_type":"Text"},{"id":"pmid:1691674","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1691674","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of pharmacology","raw_type":"Journal Article"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:1917378","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1917378/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Pharmacol","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.5683000087738037,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W1567544633","https://openalex.org/W1575855615","https://openalex.org/W1968956259","https://openalex.org/W1980934937","https://openalex.org/W1985554090","https://openalex.org/W1998547580","https://openalex.org/W2013933144","https://openalex.org/W2016584147","https://openalex.org/W2016690333","https://openalex.org/W2031648532","https://openalex.org/W2031668363","https://openalex.org/W2036209909","https://openalex.org/W2037380629","https://openalex.org/W2039836698","https://openalex.org/W2042980021","https://openalex.org/W2071544050","https://openalex.org/W2078842109","https://openalex.org/W2081678712","https://openalex.org/W2083674587","https://openalex.org/W2088804544","https://openalex.org/W2094708946"],"related_works":["https://openalex.org/W2001679924","https://openalex.org/W1575855615","https://openalex.org/W2060175105","https://openalex.org/W2091981760","https://openalex.org/W2066908035","https://openalex.org/W2082107350","https://openalex.org/W2051404852","https://openalex.org/W1975558523","https://openalex.org/W2113728177","https://openalex.org/W2014144058"],"abstract_inverted_index":{"1.":[0],"In":[1],"order":[2],"to":[3,32,109],"determine":[4],"whether":[5],"the":[6,12,23,26,37,51,88,91,111,115,132,136,148,152,173,201,206,212],"strychnine-insensitive":[7],"glycine":[8,28,117,154,194,202],"modulatory":[9,203],"site":[10,204],"on":[11,131,205],"N-methyl-D-aspartate":[13],"(NMDA)":[14],"receptor/ion":[15,208],"channel":[16,209],"complex":[17,210],"is":[18],"fully":[19],"activated":[20],"in":[21,36,55,58,76,162,169,184,211],"vivo,":[22,185],"ability":[24],"of":[25,53,74,90,104,114,135,151,200,214],"selective":[27,153,175],"receptor":[29,118,139,155],"agonist,":[30],"D-serine,":[31],"modulate":[33],"seizure":[34],"susceptibility":[35],"mouse":[38],"has":[39],"been":[40],"examined.":[41],"2.":[42],"D-Serine":[43,145],"(10-200":[44],"micrograms":[45],"per":[46],"mouse,":[47],"i.c.v.)":[48],"dose-dependently":[49],"increased":[50],"potency":[52,73],"NMDLA":[54],"inducing":[56,77],"seizures":[57,78,123,161],"Swiss":[59],"Webster":[60],"mice":[61],"by":[62,82,125,192],"approximately":[63],"3":[64],"fold.":[65],"L-Serine":[66],"was":[67,79,95,166],"without":[68,129],"significant":[69],"effect.":[70],"3.":[71],"The":[72,180],"pentylenetetrazol":[75],"also":[80,107],"enhanced":[81],"D-,":[83],"but":[84,127,165],"not":[85,189],"L-serine,":[86],"although":[87],"magnitude":[89],"shift":[92],"(1.6":[93],"fold)":[94],"considerably":[96],"less":[97,167,174],"than":[98],"for":[99],"NMDLA.":[100],"4.":[101],"Similar":[102],"doses":[103],"D-serine":[105],"were":[106,128],"able":[108],"block":[110],"anticonvulsant":[112,133],"effect":[113,130,134,150],"non-selective":[116],"antagonist,":[119,140,156,176],"kynurenic":[120,177],"acid,":[121,158],"against":[122,159,172],"induced":[124],"NMDLA,":[126],"competitive":[137],"NMDA":[138,186,207],"3-((+)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic":[141],"acid":[142],"(CPP).":[143],"5.":[144],"completely":[146],"antagonized":[147],"protective":[149],"7-chlorokynurenic":[157],"sound-induced":[160],"DBA/2":[163],"mice,":[164],"effective":[168],"this":[170],"model":[171],"acid.":[178],"6":[179],"results":[181],"indicate":[182],"that":[183],"receptors":[187],"are":[188],"maximally":[190],"potentiated":[191],"endogenous":[193],"and":[195],"suggest":[196],"an":[197],"important":[198],"involvement":[199],"pathophysiology":[213],"epilepsy.":[215]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2071881749","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
